Cholesterol in Myelin: Supply Routes, Pathological Consequences, Biophysical Governance, and Future Frontiers
Xinyu Zhu1,2,3 · Fan Zhang1 · Jian Wang4 · Guannan Wang4 · Jiajia Wang1,5
1 Zhejiang Province Key Laboratory of Anti‑Cancer Drug Research, Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
2 Taizhou Institute of Zhejiang University, Zhejiang University, Taizhou 318000, China
3 Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou 310029, China
4 College of Architecture and Engineering, Zhejiang University, Hangzhou 310058, China
5 Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou 310018, China
Abstract
Keywords
